SCHEMBL7296557

SCHEMBL7296557

NCCCN(Cc1ccc(Cl)cc1)c1ccccn1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.69
CHRM2 P08172 3/20 0.69
ADRA2A P08913 3/20 0.69
DRD1 P21728 3/20 0.69
SLC6A4 P31645 3/20 0.69
SLC6A3 Q01959 3/20 0.69
KCNH2 Q12809 3/20 0.69
TSHR P16473 3/20 0.69
SLC6A2 P23975 2/20 0.69
ADRA1A P35348 2/20 0.69
CYP1A2 P05177 2/20 0.69
CYP2C19 P33261 2/20 0.69
OPRM1 P35372 2/20 0.69
CHRM1 P11229 1/20 0.69
DRD3 P35462 1/20 0.69
KDM4E B2RXH2 5/20 0.67
ALDH1A1 P00352 3/20 0.67
PTK2 Q05397 1/20 0.67
GBA1 P04062 5/20 0.64
MEN1 O00255 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10750998 0.96 CYP2D6 (0.67) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL9866638 0.92 CYP2D6 (0.72) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL10652605 0.88 GBA1 (0.66) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL10754717 0.86 GBA1 (0.53) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL7418708 0.86 GBA1 (0.67) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL10673689 0.86 GBA1 (0.53) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL10753463 0.86 GBA1 (0.56) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL10654553 0.85 CHRM2 (0.51) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL14980581 0.85 CYP2D6 (0.85) CYP2D6CHRM2ADRA2ADRD1SLC6A4
SCHEMBL10652606 0.84 CHRM2 (0.64) CYP2D6CHRM2ADRA2ADRD1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0262448-B1 IMIDAZOLYLGUANIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1991-12-18 EP disclosed
US-4912119-A Cardiovascular disorders HEUMANN PHARMA GMBH & CO. (DE) 1990-03-27 US disclosed
EP-0113572-B1 PYRIDINE DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1988-02-03 EP disclosed
EP-0112704-B1 PYRIDINE DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1987-10-07 EP disclosed
US-4659725-A 3-(2-pyridylaminoalkylamino)cyclobutenediones and pyridones useful as histamine H1 -antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1987-04-21 US disclosed
US-4607106-A 3-(2-pyridylaminoalkylamino)thiazoles useful as histamine H1 -antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1986-08-19 US disclosed
US-4547506-A 2-Pyridylaminoakylamino-4-pyrimidones useful as histamine H1 -antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-10-15 US disclosed
US-4532246-A 2-(2-Pyridylaminoalkylamino)-4-pyrimidones SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-07-30 US disclosed
EP-0113572-A2 Pyridine derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-07-18 EP disclosed
EP-0112704-A2 Pyridine derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-07-04 EP disclosed